PDL BioPharma Inc (NASDAQ:PDLI)

2.60
Delayed Data
As of Nov 27
 +0.03 / +1.17%
Today’s Change
1.86
Today|||52-Week Range
3.50
+6.18%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
AssetsCash218.9M147.2M527.3M394.6M
 
 
 
 
 
Short Term Investment Cash-72.5M-71.7M380.1M-132.7M
 
 
 
 
 
Cash & Short Term Investments220.4M242.1M532.1M394.6M
 
 
 
 
 
 
ReceivablesReceivables58.4M151.3M84.8M87.3M
 
 
 
 
 
 
InventoriesInventories0.002.9M9.1M18.9M
 
 
 
 
 
Current AssetsOther Current Assets4.0M1.7M14.4M16.4M
 
 
 
 
 
Current Assets282.7M398.0M640.4M517.2M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross9.2M9.2M18.7M21.6M
 
 
 
 
 
Depreciation-9.2M-9.2M-11.5M-14.2M
 
 
 
 
 
Intangible Assets399.2M630.9M565.0M427.8M
 
 
 
 
 
Other Assets410.8M638.3M569.3M436.8M
 
 
 
 
 
Total Assets1.0B1.2B1.2B963.7M
 
 
 
 
 
 
LiabilitiesAccounts Payable394.0K7.0M19.8M13.1M
 
 
 
 
 
Short Term Debt25.0M0.00126.1M0.00
 
 
 
Accrued Expenses1.7M24.9M27.6M24.6M
 
 
 
 
 
Other Current Liabilities5.8M115.4M39.8M34.8M
 
 
 
 
 
Other Liabilities36.7M130.3M193.1M52.5M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt232.8M232.4M117.4M124.6M
 
 
 
 
 
Deferred Taxes-16.2M-19.3M-1.2M-12.3M
 
 
 
 
 
Other Liabilities12.2M13.0M54.8M11.3M
 
 
 
 
 
Total Liabilities320.2M460.0M397.2M234.0M
 
 
 
 
 
 
EquityMinority Interest0.00-53.0K-47.0K0.00
 
 
 
Preferred Stock0.000.000.000.00--
Common Equity696.0M751.1M845.9M729.8M
 
 
 
 
 
Total Shareholder Equity696.0M751.1M845.9M729.8M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding162.2M165.5M153.8M135.8M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.